NPHS1 and type 2 diabetes mellitus: Ultimately, nephrin's role in β cells appears to be clinically relevant, as nephrin expression is reduced in islets from individuals with type 2 diabetes, and patients with nephrin mutations show glucose intolerance (20, 24).